Chimeric Antigen Receptor T (CAR-T) cell therapy is a new type of cancer treatment that has shown great promise in treating blood cancers, such as B cell lymphomas and leukemias, and multiple myeloma.
GMP ActiveMax ® Human T Cell Activation/Expansion CD3/CD28 Beads are uniform 5.5 μm magnetic beads coated with an optimized mixture of GMP-grade mouse monoclonal antibodies targeting CD3 and CD28, ...
Efficient T-cell engineering is crucial for the success of CAR T-cell therapy research, but it requires multiple labor-intensive steps, including T-cell isolation, activation, and transduction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback